| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| B873662 | 849-55-8 | Nylidrin Hydrochloride, 99% Buphenine HCl, 99% |
C19H25NO2·HCl | |
| B797518 | 849-55-8 | Nylidrin Hydrochloride, 10mM in H2O Buphenine HCl, 10mM in H2O |
C19H25NO2·HCl | |
| O795280 | 1261289-04-6 | O-304, 10mM in DMSO O-304, 10mM in DMSO |
C16H11Cl2N3O2S | |
| O883556 | 1261289-04-6 | O-304 , 99% O-304 , 99% |
C16H11Cl2N3O2S | |
| O883220 | 1329488-46-1 | O-Desmethyl Mebeverine acid D5 , 98% O-Desmethyl Mebeverine acid D5 , 98% |
C15H18D5NO3 | |
| H937830 | 163217-74-1 | O-Hydroxy atorvastatin lactone, ≥98% 2-Hydroxy atorvastatin lactone, ≥98% |
C33H33FN2O5 | |
| O938366 | 887196-29-4 | O-Methyl Atorvastatin hemicalcium, ≥98% O-Methyl Atorvastatin hemicalcium, ≥98% |
C34H36CaFN2O5+ | |
| O882603 | 1416561-90-4 | O-Propargyl-Puromycin, 95% O-Propargyl-Puromycin, 95% |
C24H29N7O5 | |
| O860994 | 175135-47-4 | O4I1, >98% O4I1, >98% |
C16H15NO2 | |
| O793153 | 175135-47-4 | O4I1, 10mM in DMSO O4I1, 10mM in DMSO |
C16H15NO2 | |
| O860993 | 165682-93-9 | O4I2, >98% O4I2, >98% |
C12H11ClN2O2S | |
| O795801 | 165682-93-9 | O4I2, 10mM in DMSO O4I2, 10mM in DMSO |
C12H11ClN2O2S | |
| O879251 | 382607-78-5 | O6BTG-octylglucoside, 98% O6BTG-octylglucoside, 98% |
C24H34BrN5O7S | |
| O880790 | 1984862-48-7 | OABK hydrochloride , ≥97% OABK hydrochloride , ≥97% |
C14H20ClN5O4 | |
| O876997 | 856095-68-6 | OBA-09 , ≥99% OBA-09 , ≥99% |
C10H8O5 | |
| A873856 | 949142-50-1 | Obinutuzumab, ≥95% afutuzumab, ≥95% |
||
| O873492 | 111540-00-2 | Ochromycinone (STA-21), 99% Ochromycinone (STA-21), 99% |
C19H14O4 | |
| O795088 | 111540-00-2 | Ochromycinone (STA-21), 10mM in DMSO Ochromycinone (STA-21), 10mM in DMSO |
C19H14O4 | |
| O872199 | 1016535-83-3 | Oct3and4-inducer-1, BR Oct3and4-inducer-1, BR |
C15H12FNO | |
| O878432 | 56391-55-0 | Octazamide, 98% Octazamide, 98% |
C13H15NO2 |